← Leaderboards
Satish K Madala
University Of Cincinnati
$7,239,015
Attributed
$7,363,258
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,363,258 · 5
By mechanism
R01$6,433,095 · 2
R21$700,663 · 2
R03$229,500 · 1
Top collaborators
- Anil Jegga2 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Kathryn Ann Wikenheiser-Brokamp$6,677,920
Others in their field
Top investigators on “Fibrosis”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Peter Scott Heeger · Case Western Reserve University$58,406,959
- John F Engelhardt · University Of Iowa$51,265,353
- David Albert Schwartz · Va Eastern Colorado Health Care System$41,842,857
- Richard C Boucher · University Of North Carolina Chapel Hill$33,165,173
- Bruce A. Stanton · Dartmouth College$32,494,343
Research focus
FibrosisProductionLungInnovationGenesBleomycinLesionIn VitroIn VivoFibroblastsMouse ModelPulmonary FibrosisCellsPathogenesisAttenuatedPeripheralAreaBiochemicalCicatrixDepositionExtracellular MatrixMolecularAdultComplex
Grant awards (22)
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis$488,723
R01 · FY2025 · HL · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$453,634
R01 · FY2025 · HL · contact PI
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis$478,948
R01 · FY2024 · HL · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$449,264
R01 · FY2024 · HL · contact PI
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis$488,723
R01 · FY2023 · HL · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$530,280
R01 · FY2022 · HL · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$496,006
R01 · FY2022 · HL · contact PI
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis$495,468
R01 · FY2022 · HL · contact PI
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis$36,953
R01 · FY2022 · HL · contact PI
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis$537,519
R01 · FY2021 · HL · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$389,919
R01 · FY2021 · HL · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$389,917
R01 · FY2020 · HL · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$393,128
R01 · FY2019 · HL · contact PI
IL-31 Regulation of Immunopathology in Pulmonary Fibrosis$206,290
R21 · FY2019 · AG · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$395,371
R01 · FY2018 · HL · contact PI
IL-31 Regulation of Immunopathology in Pulmonary Fibrosis$245,887
R21 · FY2018 · AG · contact PI
WT1 REGULATION OF PULMONARY FIBROSIS$409,242
R01 · FY2017 · HL · contact PI
Integrative analysis of multi-omics data to target fibroblast activation in IPF$120,627
R21 · FY2017 · HL · contact PI
Integrative analysis of multi-omics data to target fibroblast activation in IPF$127,859
R21 · FY2016 · HL · contact PI
THE ROLE OF IL-31 IN TH2 CYTOKINE-DRIVEN SYSTEMIC SCLEROSIS$76,500
R03 · FY2015 · AR · contact PI
THE ROLE OF IL-31 IN TH2 CYTOKINE-DRIVEN SYSTEMIC SCLEROSIS$76,500
R03 · FY2014 · AR · contact PI
THE ROLE OF IL-31 IN TH2 CYTOKINE-DRIVEN SYSTEMIC SCLEROSIS$76,500
R03 · FY2013 · AR · contact PI